NEW YORK, November 29, 2016 /PRNewswire/ --
For today, Stock-Callers.com reviews the following equities in the Medical Laboratories and Research space: Thermo Fisher
Scientific Inc. (NYSE: TMO), Bruker Corp. (NASDAQ: BRKR), VWR Corp. (NASDAQ: VWR), and Laboratory Corp. of America Holdings
(NYSE: LH). These companies are part of the Healthcare sector which was mostly down on Monday, November
28th, 2016, with the NYSE Health Care Index declining almost 0.7%, and shares of health care companies in the S&P 500
dropping nearly 0.8% as a group. These stocks research reports can be downloaded now by simply registering for free at:
http://stock-callers.com/registration
Thermo Fisher Scientific
On Monday, shares in Waltham, Massachusetts headquartered Thermo Fisher Scientific Inc.
recorded a trading volume of 3.63 million shares, which was above their three months average volume of 1.79 million shares. The
stock ended the session 2.68% lower at $140.32. The Company's shares are trading 5.30% below their
200-day moving average. Moreover, shares of Thermo Fisher Scientific, which provides analytical instruments, equipment, reagents
and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics worldwide, have a
Relative Strength Index (RSI) of 31.19.
On November 10th, 2016, Thermo Fisher's board of directors
declared a quarterly cash dividend of $0.15 per share. The dividend will be paid on January 16th, 2017, to shareholders of record as of December 15th, 2016.
On November 10th, 2016, research firm Leerink Partners resumed its 'Outperform' rating on the
Company's stock. Your complete research report on TMO can be retrieved for free at:
http://stock-callers.com/registration/?symbol=TMO
Bruker
Billerica, Massachusetts headquartered Bruker Corp.'s stock closed the day 0.48% lower at
$22.85 and with a total trading volume of 520,382 shares. The Company's shares have advanced 13.74%
in the past month and 1.20% in the previous three months. The stock is trading 4.06% above its 50-day moving average.
Additionally, shares of Bruker, which together with its subsidiaries, designs and manufactures scientific instruments, and
analytical and diagnostic solutions worldwide, have an RSI of 57.37.
On November 10th, 2016, research firm Leerink Partners resumed its 'Market Perform' rating on
the Company's stock.
On November 22nd, 2016, Bruker announced that it has completed the acquisition of the
preclinical PET imaging business of Oncovision, a leading provider of innovative medical imaging devices. Bruker had
previously announced an agreement to acquire this business in September 2016. Financial terms were
not disclosed. BRKR free report is just a click away at:
http://stock-callers.com/registration/?symbol=BRKR
VWR Corp.
Shares in Radnor, Pennsylvania-based VWR Corp. recorded a trading volume of 1.83 million
shares, which was higher than their three months average volume of 686,320 shares. The stock ended yesterday's trading session
2.93% lower at $26.21. The Company's shares are trading below their 50-day moving average by 4.34%.
Furthermore, shares of VWR Corp., which together with its subsidiaries, operates as an independent provider of laboratory
products, services, and solutions to the life science, general research, and applied markets, have an RSI of 40.40.
On November 03rd, 2016, VWR Corp. announced the acquisition of two companies, Reliable
Biopharmaceutical and BioArra. Reliable Biopharmaceutical, a manufacturer of high quality active pharmaceutical ingredients
(APIs) and high purity ingredients (HPIs) such as cGMP excipients and advanced intermediates for the biopharmaceutical industry,
enhances VWR's growing custom chemical and biochemical manufacturing portfolio. Reliable Biopharmaceutical offers
highly-flexible, scalable and solution oriented production ranging from small batch clinical manufacturing to full scale
commercial production. BioArra is a leading producer of U.S. origin serum-based products for use in research and production.
Founded in 2008 and headquartered in Eagleville, Pennsylvania BioArra produces semi-processed
serum from various USDA approved supplier locations. The company did not disclose the financial details of the transaction.
On November 04th, 2016, research firm Bank of America/ Merrill downgraded the Company's stock
rating from 'Buy' to 'Neutral'. Sign up for your complimentary research report on VWR at:
http://stock-callers.com/registration/?symbol=VWR
Laboratory Corp. of America
Burlington, North Carolina headquartered Laboratory Corp. of America Holdings' stock finished
Monday's session 1.41% lower at $125.71 with a total trading volume of 722,735 shares. The
Company's shares have advanced 1.42% in the last one month and 1.67% since the start of this year. The stock is trading below its
200-day moving average by 1.70%. Additionally, shares of Laboratory Corp. of America, which operates as an independent clinical
laboratory company worldwide, have an RSI of 45.18.
On November 21st, 2016, Laboratory Corp. announced that IDG's Computerworld recently recognized
Dimitris Agrafiotis, Ph.D., chief data officer and head of technology products for Covance Drug
Development, as a 2017 Premier 100 Technology Leaders honoree. Covance is the drug development business of Laboratory Corp.
Register for free on Stock-Callers.com and download the latest research report on LH at:
http://stock-callers.com/registration/?symbol=LH
Stock Callers:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment
newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments.
One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a
third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on
analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is
believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed
any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently
reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or
interfere in the application of such procedures by the third-party research service company to the articles, documents or
reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or
the Reviewer in any way.
NO WARRANTY
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this
document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss
arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document.
Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing
of the information, or (2) warrant any results from use of the information. The included information is subject to change without
notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities
mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers
in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://stock-callers.com/legal-disclaimer/
CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a
company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA